Unity Biotechnology, Inc.
UBXDelisted Aug 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001463361
Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.
Holders of 5% or more of UBX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Unity Biotechnology, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 13G/A | 9.17%1.58M shares | – | May 15, 20251 filing | May 15, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Unity Biotechnology, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:30 PM ET | ARCH Venture Fund VII, L.P.and 7 others | 13G/A | 0.00%0 shares | –Below 5% | Sep 30, 2025 | SEC |
| May 15, 20254:31 PM ET | Alyeska Investment Group, L.P.and 2 others | 13G/A | 9.17%1.58M shares | – | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Unity Biotechnology, Inc. shares.
No Form 144 notices for Unity Biotechnology, Inc. are on file.